Publication Details
Abstract
This article explores the clinical, nutritional, and developmental implications of dietary interventions in infants born with intrauterine growth retardation (IUGR), a condition characterized by suboptimal fetal growth and reduced birth weight relative to gestational age. As a significant contributor to neonatal morbidity and mortality worldwide, IUGR presents unique challenges in postnatal management, particularly concerning nutritional rehabilitation and growth optimization. The study synthesizes current evidence on how targeted dietary strategies can influence the short- and long-term health outcomes of these vulnerable neonates. The research provides a comprehensive review of the physiological alterations observed in IUGR infants, such as impaired nutrient absorption, reduced fat and muscle mass, delayed organ maturation, and compromised metabolic programming. These factors contribute to increased nutritional demands immediately after birth, making timely and appropriate feeding interventions crucial for survival and recovery. The article evaluates the effectiveness of various dietary approaches, including exclusive breastfeeding, fortified human milk, preterm and IUGR-specific formulas, and the use of parenteral nutrition where necessary. It emphasizes the irreplaceable immunological and developmental benefits of mother’s milk, especially for IUGR infants, while acknowledging that supplementation or formula alternatives may be required due to maternal insufficiency or specific clinical indications. Key nutritional elements such as proteins, long-chain polyunsaturated fatty acids (LCPUFAs), calcium, iron, and trace minerals are examined for their critical roles in promoting catch-up growth, neurodevelopment, and immunity. Additionally, the article analyzes data from clinical trials and cohort studies indicating that early and aggressive nutritional intervention can significantly improve growth parameters, reduce hospital stays, and enhance cognitive outcomes in IUGR infants. It also discusses the importance of individualized nutritional planning, involving regular monitoring of weight, length, head circumference, and biochemical markers to tailor feeding regimens according to each infant’s needs and tolerance levels. Beyond the neonatal period, the article considers the long-term consequences of both undernutrition and overnutrition in IUGR infants, such as increased risk for metabolic syndrome, insulin resistance, cardiovascular disorders, and obesity in later life. As such, it advocates for a balanced and closely supervised dietary approach that supports adequate growth without promoting excessive adiposity. The article concludes with a call for integrated clinical protocols, interdisciplinary collaboration, and caregiver education to ensure optimal dietary support for IUGR infants. It underscores the need for more high-quality randomized trials to further refine dietary strategies and establish evidence-based guidelines for diverse clinical settings. This article contributes valuable insights to neonatal nutrition, underlining the critical role of tailored dietary interventions in improving survival, growth, and developmental outcomes in infants born with intrauterine growth retardation.